Abstract Details
|
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Edward J. Wild, MBBS, PhD, MRCP (UCL Institute of Neurology) | Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Wild has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Skyhawk Therapeutics. Dr. Wild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis Pharmacauticals. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman La Roche. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vico Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. The institution of Dr. Wild has received research support from CHDI Foundation (non-profit). |